Chinwe Iwu-Jaja, PhD

Public health researcher | Vaccines, AMR & policy | Evidence synthesis & strategy | Founder, Evidence Impact Consulting 🌍📊💉

[Chinwe Iwu-Jaja, PhD @ChinweJaja]

Friends, I have just created a new YouTube channel, where I will make weekly videos to educate and inform you on accurate health information based on scientific evidence.

I also debunk a lot of myths and misinformation.

Please subscribe here: https://t.co/gjxBgRsuGr

[CharlesShey Wiysonge @CharlesShey]

The AVAREF toolkit facilitated joint reviews across multiple therapeutic areas, including vaccines for meningococcal disease, rotavirus, malaria, TB, & HIV. The toolkit represents a milestone in African regulatory harmonization.
Read more at: https://t.co/1wfT5kdhfG

[CharlesShey Wiysonge @CharlesShey]

AVAREF addressed critical challenges in regulatory oversight and clinical development through harmonized submission processes, joint reviews, capacity building, and strong partnerships with global health organizations. Read more at: https://t.co/2wnH5HenLn

[CharlesShey Wiysonge @CharlesShey]

AVAREF facilitated a joint review procedure for the M72/AS01E-4 Mycobacterium tuberculosis vaccine phase 3 clinical trial, involving national regulatory authorities and ethics committees from Kenya, Malawi, Mozambique, and Zambia.
Read more at: https://t.co/3x4EYIHhpl

[CharlesShey Wiysonge @CharlesShey]

Through partnerships, training, mentorship, information sharing, & development of common technical guidance documents, AVAREF has facilitated successful clinical development & regulatory approval of vaccines multiple priority diseases.
Read more at: https://t.co/FdWwLlH40w

[CharlesShey Wiysonge @CharlesShey]

This essay highlights AVAREF's role in supporting regulatory oversight and accelerating R&D during public health emergencies, particularly during the Ebola epidemic and the COVID-19 pandemic.
Read more at: https://t.co/Z2Z1H2iTK9

[CharlesShey Wiysonge @CharlesShey]

Established by WHO in 2006, AVAREF has played a central role in promoting regulatory collaboration, harmonization, & reliance approaches that support timely & high-quality clinical development of priority health products in Africa
Read this editorial at: https://t.co/2Ld16Ip0uF

[Tedros Adhanom Ghebreyesus @DrTedros]

Thank you my brother, @PresidencyZA Cyril Rhamaposa, for your strong address at #WHA78, and for #SouthAfrica's steady co-leadership of the #PandemicAccord negotiations.

Together, for a healthier, safer, fairer Africa and the world!

[Chinwe Iwu-Jaja, PhD @ChinweJaja]

Our latest paper: https://t.co/U47c0wTgoO #amr-insights

[Chinwe Iwu-Jaja, PhD @ChinweJaja]

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever) - Gloeck, NR - 2025 | Cochrane Library https://t.co/AdJOtmKzfH

[Tedros Adhanom Ghebreyesus @DrTedros]

With @WHO's support, @MinofHealthUG has started a vaccine trial against #Ebola Sudan virus today. The trial will enroll contacts of people with the disease, and contacts of the contacts.

This vaccination trial was initiated with record speed, only three days since the outbreak was declared, while ensuring full compliance with international and national regulatory and ethical requirements. It is also the first trial to assess the clinical efficacy of a vaccine against Ebola Sudan virus disease.

This trial demonstrates the importance of investing in R&D for vaccines and treatments and outbreak response preparedness, as well as partnerships. We thank @Makerere University and @UVRIug for their leadership, as well as @AfricaCDC, @CEPIvaccines, @EC_HERA and @IDRC_CRDI for their collaboration on this lifesaving effort.

WHO will continue supporting the government in a comprehensive response to bring the outbreak under control.

[CharlesShey Wiysonge @CharlesShey]

Journal Supplement: 50 years of immunisation in Africa.

#Openaccess.
No publication costs. Open access publication. Rigorous but constructive peer review

#vaccineswork #vaccinationsaveslives

Read more and submit at
https://t.co/OAKTla6Jdn

[WHO African Region @WHOAFRO]

Join us for the AVAREF webinar on 'Closing the real-life safety gap in Africa – the potential of Pharmacoepidemiology'.

🗓️ 24 October 2024
⏰ 2-3:30 PM (GMT+1)

📲 Scan the QR code to register or click here➡️: https://t.co/LC1A918Rli

[Dr Matshidiso Moeti @MoetiTshidi]

Vaccines are among the most powerful innovations in history. In Africa, vaccines have saved over 50M lives in the past 50 years, but many children are still unvaccinated.
There’s a need for substantial investments by govts & partners to protect children from preventable diseases.

[Dr Matshidiso Moeti @MoetiTshidi]

While there is a high-level political commitment to eliminate this disease, this must be translated into concrete actions to cut costs & increase access to the tools we know will help accelerate our efforts to change this tragic situation.

[Dr Matshidiso Moeti @MoetiTshidi]

Globally, a woman dies of cervical cancer every 2 minutes. Africa accounts for 23% of the deaths. I must reiterate what we all know: we can completely prevent cervical cancer through vaccination & screening. The major barriers are cost & access.

[WHO African Region @WHOAFRO]

Join us for a webinar discussing AVAREF's role in capacity building for clinical trials in Africa.
📅 Thursday, August 22, 2024
🕒 2-3:30 PM (GMT+1)
Discover how the African Vaccine Regulatory Forum (AVAREF) is shaping the future of clinical trials across the continent.
Register ➡️: https://t.co/a4GBLnqMiA

[WHO African Region @WHOAFRO]

If #AntimicrobialResistance (AMR) gets out of control, we’ll run out of treatment options. 💊

#AMR is largely driven by the misuse and overuse of antimicrobials.

We must use medication responsibly to prevent #AMR.

[Dr Matshidiso Moeti @MoetiTshidi]

Disinformation erodes trust in public health & puts lives in danger. I welcome @MinofHealthUG's statement debunking misleading claims on vaccines & health issues.

Let's all promote access to credible information for better health decisions.

Learn more➡️: https://t.co/4fKx9fcwHx

[WHO African Region @WHOAFRO]

Save the Date🗓️!

Join us for the #AVAREF June webinar discussing the safety & immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults with Dr Paul Wichgers Schreur.

Register: https://t.co/h2miweNcPT

#EndingDiseaseInAfrica

[WHO African Region @WHOAFRO]

Join the #AVAREF2024 webinar on May 23 at 2 PM (GMT+1) with Prof. Ariel E. Arias.

Gain insights on post-market drug surveillance in Africa and join the mission to #EndingDiseaseInAfrica.

Register here ➡️: https://t.co/nmtboxuw7c or scan the QR code below ⬇️.